MaxLife review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
MaxLife advertises compounded semaglutide from $89 a month with a Starter Kit Plan. What the month after that costs is not published anywhere on the site.
- No month-to-month price published
- States not published
- FDA warning letters: 1 of 1 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
This link pays us nothing. It's here because the price is checkable.
The verdict
A starting price with no second month behind it, and an FDA warning letter from February over website claims about the same two drugs. The site has since fixed the claims the letter named.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Compounded semaglutide
- From $89 a month with a Starter Kit Plan
- Compounded tirzepatide
- From $120 a month, same footnote
- Recurring price
- Not published on any page
- FDA warning letter
- February 20, 2026, to MaxLife Technologies Inc. dba Maxlife
- Claims FDA cited
- None remain on the pages we read
- Company
- Maxlife Technologies Inc., Irvine, California
- Pharmacy partners
- Hallandale, Red Rock and Strive, named in its FAQ
- Medication refunds
- Not available, per its own FAQ
- Cancelation
- At least 30 days before the next billing period
- States served
- Claimed as all 50; no list published
Pros and cons
What we like
- It names three pharmacy partners by company name, which almost nothing else on this roster does.
- The corporate entity and a real street address are published in its privacy notice.
- It states outright that it is not a drug manufacturer or a compounding pharmacy.
- Its FAQ correctly distinguishes trial results for brand-name products from what has been established for compounded versions.
- No long-term contract is required and the cancelation window is stated.
What could be better
- The only published price is a starter-kit rate; the recurring price appears nowhere.
- The product page's Pricing tab opens onto a description rather than a price.
- The intake at its app subdomain renders no readable content, so a price cannot be reached there either.
- An FDA warning letter issued in February 2026 cited website claims about these same two drugs as misbranding.
- Medication costs are not refundable, per its own FAQ.
- Its state coverage is a claim of all 50 rather than a published list.
What it is
MaxLife sells two products: compounded semaglutide and compounded tirzepatide, each with its own page. It describes itself as a patient management platform collaborating with independent physicians, not a manufacturer or a pharmacy, which is how most telehealth GLP-1 prescriptions are written now.
The company is Maxlife Technologies Inc., with a mailing address on Technology Drive in Irvine, California, published in its own privacy notice. It names its pharmacy partners too — Hallandale, Red Rock and Strive — which is more pharmacy disclosure than most of this roster manages.
On February 20, 2026, FDA's Center for Drug Evaluation and Research issued a warning letter to MaxLife Technologies Inc. dba Maxlife at that same Irvine address.
The letter concerns website claims about compounded semaglutide and tirzepatide. FDA wrote that the product labeling pictured on the site identified "Maxlife" in a way that suggested Maxlife compounded the drugs when it does not, and quoted six claims from the site including "FDA Approved" and that the treatment "has been clinically tested and FDA-approved for effective weight management." Compounded drugs are not FDA-approved, and FDA cited the products as misbranded on that basis.
Those claims are gone. Across the three MaxLife pages we read in full, FDA is mentioned ten times, and every one is either about a brand-name drug in a cited trial or a correct disclaimer that compounded medications are not FDA-approved.
The site now also answers the letter's first point directly, in its own FAQ: it says it is not a drug manufacturer or a compounding pharmacy and names the pharmacies that prepare the products. A letter discloses a concern; it does not settle what a company is today, and what this company publishes today is different from what the letter quoted.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutideThe page's own asterisk reads "With a Starter Kit Plan". No rate for a later month is published. | not published | $89/mo | not comparable | September 2026 |
| Compounded tirzepatideSame structure, same footnote, same missing recurring rate. | not published | $120/mo | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
Both product pages print one figure — $89 a month for semaglutide, $120 for tirzepatide — and footnote it to a Starter Kit Plan. No page says what month two costs.
The semaglutide page has a three-tab block labeled Benefits, Pricing and Description. Opening Pricing produces a paragraph about how the medication works. The FAQ beneath it answers thirteen questions about dosing, side effects, shipping, cancelation and pharmacy partners, and none of them is what it costs after the starter kit.
The intake at its own app subdomain is the last place a price could be, and it renders nothing at all to read. So the one number a shopper comes for is the number this site will not print.
The terms it does publish around the money are clear enough: medication and supplies are included in the membership fee, there is no long-term contract, cancelation requires notice at least 30 days before the next billing period, and medication costs are not refundable.
Its state claim is the familiar shape — "MaxLife provides services in all 50 U.S. states" — asserted in an FAQ answer rather than enumerated anywhere.
Who it's wrong for
- Anyone who needs to know the recurring price. The starter-kit figure is the only price published, and the Pricing tab does not contain one.
- Anyone comparing on total cost. Without a second-month figure there is nothing to compare.
- Anyone who wants the FDA record to be part of the decision. The letter is six months old and the claims it named are gone, but the letter is real and it is about these two drugs.
- Anyone who wants a state list rather than a nationwide claim.
- Anyone expecting a refund on medication. Its FAQ says medication costs are not refundable.
How MaxLife works
Check eligibility
A short online form, which its own three-step explanation says takes about five minutes.
A provider reviews it
Usually within 24 hours, with a video visit where the state requires one.
A partner pharmacy ships it
Hallandale, Red Rock or Strive prepares the medication; shipping frequency follows the billing period and the dose.
Cancel with notice
At least 30 days before the next billing period begins. Medication costs are not refundable.
Medications available
- Compounded semaglutideCompoundedFrom $89 a month
With a Starter Kit Plan. No recurring price is published.
- Compounded tirzepatideCompoundedFrom $120 a month
Same footnote, same missing recurring price.
Is MaxLife legit?
MaxLife is operated by Maxlife Technologies Inc., 220 Technology Dr Ste. 215, Irvine, CA 92618. We read that off the company’s own privacy notice on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Legal entityMaxlife Technologies Inc.
- Address220 Technology Dr Ste. 215, Irvine, CA 92618
- Pharmacy namedHallandale, Red Rock and Strive
- FDA warning letterFebruary 20, 2026, over website claims about these two drugs
- Claims cited by FDANot present on the pages we read today
- Drug formCompounded; the site states these are not subject to FDA approval
- States servedClaimed as all 50; no list published
Common questions
How much does MaxLife cost per month?
Its pages publish one figure each — from $89 a month for compounded semaglutide and from $120 for tirzepatide — and both are footnoted to a Starter Kit Plan. What a later month costs is not published on any page we could read.
Does MaxLife have an FDA warning letter?
Yes. On February 20, 2026, FDA's Center for Drug Evaluation and Research wrote to MaxLife Technologies Inc. dba Maxlife over website claims about compounded semaglutide and tirzepatide, including "FDA Approved", and over labeling that suggested MaxLife compounded the drugs itself.
Are those FDA-approved claims still on the MaxLife site?
Not on the pages we read. FDA is mentioned ten times across its homepage and two product pages, and every mention is either about a brand-name drug in a cited trial or a disclaimer that compounded medications are not FDA-approved.
Which pharmacy does MaxLife use?
Its FAQ names three: Hallandale Pharmacy, Red Rock Pharmacy and Strive Pharmacy. It also states that MaxLife itself is not a drug manufacturer or a compounding pharmacy.
Can I get a refund from MaxLife?
Its FAQ says you may cancel with at least 30 days' notice before your next billing period and that no long-term contract is required, but that medication costs are not refundable.
Which states does MaxLife serve?
Its FAQ says it provides services in all 50 U.S. states. That is a claim rather than a published list, and no page we read enumerates states.
Why we gave MaxLife a F
Read the full grading rationale
MaxLife publishes a starting price and nothing else. Both product pages say "Starting at $89/mo" — $120 for tirzepatide — and both footnote it to a "Starter Kit Plan"; no page says what month two costs, the "Pricing" tab on the product page opens onto the description, and the intake at app.maxlife.com renders nothing at all. So the one number this site exists to tell you is the one it will not print. It also carries an FDA warning letter. On February 20, 2026, FDA's Center for Drug Evaluation and Research wrote to MaxLife Technologies Inc. dba Maxlife at the Irvine address MaxLife's own privacy notice publishes, over website claims about compounded semaglutide and tirzepatide — labeling that suggested MaxLife compounded the drugs when it does not, and claims including "FDA Approved" and "clinically tested and FDA-approved" on products that are neither. That is a disclosure, not a verdict, and the site has moved: across the three pages we read in full, all ten FDA references are now either about a brand-name drug in a cited trial or a correct disclaimer, it states outright that it is not a compounding pharmacy, and it names Hallandale, Red Rock and Strive as its pharmacy partners — which is more pharmacy disclosure than most of this roster offers. Its state claim, "all 50 U.S. states", is asserted rather than listed.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed MaxLife
- We read the homepage, both product pages, the terms of service and the privacy notice in full on the same day, and opened the product page's Benefits, Pricing and Description tabs on a fresh load.
- The FDA warning-letter screen ran on the company's own domain and the Irvine address its privacy notice publishes, with a known-positive and a known-negative control passing in the same run. It returned one match, and we then read the letter itself on fda.gov rather than reporting the search result.
- The statement that the cited claims are gone is a count, not an impression: ten FDA references across three pages, each one read and classified by hand.
- We tried the intake at the company's app subdomain to look for a recurring price. It returns a page with no readable text, so no figure was obtained there and none is claimed.
The 2 pages we read — all on
- Compounded semaglutide page
Compounded Semaglutide Online A physician-guided GLP-1 weight loss medication Starting at $89/mo* Get Started *With a Starter Kit Plan
- Compounded tirzepatide page
Semaglutide A physician-guided GLP-1 medication One receptor · a common, gentler starting choice Starting at $89/mo Get Started Tirzepatide A physician-guided GLP-1/GIP medication Two receptors · strongest average results in head-to-head data Starting at $120/mo Get Started
This link pays us nothing. It's here because the price is checkable.
Alternatives to MaxLife
| Provider | Grade | Cheapest price |
|---|---|---|
| Science & Co | CCaveat | $89/mo |
| Invyncible | CCaveat | $88/mo |
| CoreAge Rx | CCaveat | $93/mo |
| TRT Nation | CCaveat | $80/mo |
| NiceRx | CCaveat | $79/mo |